|
|
Mindray Medical CFO, Ronald Ede, to Participate as a Panelist at the Financial Times' Global Pharmaceutical and Biotechnology ConferenceNovember 04, 2009
Financial Times' Global Pharmaceutical and Biotechnology Conference
United Kingdom
SHENZHEN, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical
International Limited (NYSE: MR), a leading developer, manufacturer and
marketer of medical devices worldwide, announced today that Mr. Ronald Ede,
Chief Financial Officer, will participate in a panel discussion at the
Financial Times' Global Pharmaceutical and Biotechnology Conference, which
will be held at the Millennium Mayfair Hotel in London on November 17-18, 2009.
Mr. Ede will present as a guest panelist during the panel entitled
"Exploring New Avenues for Innovation, Growth and Profitability -- The Role of
Emerging Markets," which will take place on November 17, 2009 from 3:15-4:15
GMT.
To learn more about the Financial Times' Global Pharmaceutical and
Biotechnology Conference, please visit http://www.ftconferences.com/pharmabio .
About Mindray
We are a leading developer, manufacturer and marketer of medical devices
worldwide. We maintain global headquarters in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales offices in major
international markets. From our main manufacturing and engineering base in
China and through our worldwide distribution network, we are able to supply
internationally a broad range of products across three primary business
segments, comprised of patient monitoring and life support products, in-vitro
diagnostic products and medical imaging systems. For more information, please
visit http://ir.mindray.com .
For further information, please contact:
In the U.S.:
FD
Evan Smith, CFA
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
Cathy Gao
Tel: +86-755-2658-2518
Email: cathy.gao@mindray.com
SOURCE Mindray Medical International Limited |
|
|
  
|
